Resultados globales: 2 registros encontrados en 0.02 segundos.
Artículos, Encontrados 2 registros
Artículos Encontrados 2 registros  
1.
8 p, 1.5 MB Non-pharmacological Effects in Switching Medication : The Nocebo Effect in Switching from Originator to Biosimilar Agent / Kristensen, Lars Erik (Lund University. Department of Internal Medicine, Rheumatology) ; Alten, Rieke (Schlosspark Klinik, University Medicine Berlin. Department of Internal Medicine, Rheumatology) ; Puig Sanz, Lluís (Institut d'Investigació Biomèdica Sant Pau) ; Philipp, Sandra (Charité - Universitätsmedizin Berlin) ; Kvien, Tore K. (Diakonhjemmet Hospital. Department of Rheumatology) ; Mangues, Ma Antonia (Institut d'Investigació Biomèdica Sant Pau) ; van den Hoogen, Frank (Radboud University Medical Centre. Department of Rheumatology) ; Pavelka, Karel (Institute of Rheumatology) ; Vulto, Arnold G. (KU Leuven. Department of Pharmaceutical and Pharmacological Sciences) ; Universitat Autònoma de Barcelona
The nocebo effect is defined as the incitement or the worsening of symptoms induced by any negative attitude from non-pharmacological therapeutic intervention, sham, or active therapies. When a patient anticipates a negative effect associated with an intervention, medication or change in medication, they may then experience either an increase in this effect or experience it de novo. [...]
2018 - 10.1007/s40259-018-0306-1
Biodrugs, Vol. 32 (september 2018) , p. 397-404  
2.
11 p, 634.6 KB Diacerein : Benefits, Risks and Place in the Management of Osteoarthritis. An Opinion-Based Report from the ESCEO / Pavelka, Karel (Charles University) ; Bruyère, Olivier (Liège, Belgium) ; Cooper, Cyrus (Southampton, UK) ; Kanis, John A. (Sheffield, UK) ; Leeb, Burkhard F. (State Hospital Stockerau) ; Maheu, Emmanuel (St-Antoine Hospital) ; Martel-Pelletier, Johanne ; Monfort, Jordi (Hospital del Mar (Barcelona, Catalunya)) ; Pelletier, Jean-Pierre (University of Montreal Hospital Research Centre (CRCHUM)) ; Rizzoli, René (Geneva University Hospitals (Suïssa)) ; Reginster, Jean-Yves (Université de Liège) ; Universitat Autònoma de Barcelona. Departament de Medicina
Diacerein is a symptomatic slow-acting drug in osteoarthritis (SYSADOA) with anti-inflammatory, anti-catabolic and pro-anabolic properties on cartilage and synovial membrane. It has also recently been shown to have protective effects against subchondral bone remodelling. [...]
2016 - 10.1007/s40266-016-0347-4
Drugs & Aging, Vol. 33 (february 2016) , p. 75-85  

¿Le interesa recibir alertas sobre nuevos resultados de esta búsqueda?
Defina una alerta personal vía correo electrónico o subscríbase al canal RSS.